Short Description

NGS genetic DNA test detecets for variant and mutation detection in CEBPA gene for Leukemia, acute myeloid, somatic

PreTest Information

Clinical History of Patient who is going for CEBPA Gene Leukemia, acute myeloid, somatic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CEBPA Gene Leukemia, acute myeloid, somatic NGS Genetic DNA Test gene CEBPA

Detail Description

CEBPA Gene Leukemia - Symptoms, Diagnosis, and NGS Genetic DNA Test Cost

Leukemia is a type of cancer that affects the blood and bone marrow. Acute myeloid leukemia (AML) is a subtype of leukemia that starts in the bone marrow and can spread to other parts of the body. It is a rapidly progressing cancer that requires prompt diagnosis and treatment. One of the genes that can be involved in AML is the CEBPA gene.

CEBPA Gene

The CEBPA gene is located on chromosome 19 and encodes a protein that plays a role in regulating the differentiation of cells in the bone marrow. Mutations in the CEBPA gene can disrupt this process and lead to the development of AML.

Symptoms of AML

The symptoms of AML can vary depending on the individual and the stage of the cancer. Some common symptoms include:

• Fatigue
• Shortness of breath
• Pale skin
• Frequent infections
• Bruising or bleeding easily
• Swollen lymph nodes
• Joint or bone pain
• Unexplained weight loss

If you are experiencing any of these symptoms, it is important to see a doctor as soon as possible for an accurate diagnosis.

Diagnosis of AML

AML can be diagnosed through a combination of physical exams, blood tests, and bone marrow biopsies. These tests can help determine the type of leukemia and the extent of its spread. In some cases, genetic testing may be necessary to identify specific gene mutations that are driving the cancer.

NGS Genetic DNA Test for CEBPA Gene Leukemia

NGS (Next Generation Sequencing) is a type of genetic testing that can analyze multiple genes at the same time. This makes it a useful tool for identifying specific gene mutations that may be involved in AML, including mutations in the CEBPA gene. NGS testing can provide a more comprehensive picture of the genetic makeup of a cancer, which can help guide treatment decisions.

Cost of NGS Genetic DNA Test for CEBPA Gene Leukemia

The cost of NGS genetic testing for CEBPA gene leukemia can vary depending on the laboratory and the specific tests performed. At DNA Labs India, we offer NGS testing for AML at a cost of INR 20,000. This includes the cost of the test and the analysis of the results.

Conclusion

If you are experiencing symptoms of AML, it is important to see a doctor as soon as possible for an accurate diagnosis. Genetic testing, including NGS testing for the CEBPA gene, can provide valuable information for guiding treatment decisions. At DNA Labs India, we offer affordable and accurate genetic testing services for AML and other types of cancer.